Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Azithromycin through the Lens of the COVID-19 Treatment
Georgia G. Kournoutou, George P. Dinos
Antibiotics (2022) Vol. 11, Iss. 8, pp. 1063-1063
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Strategies for the development and approval of COVID-19 vaccines and therapeutics in the post-pandemic period
Danyi Ao, Xuemei He, Jian Liu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 27
Bacterial Identification and Antibiotic Sensitivity Tests of COVID-19 Patients at ICU Wahidin Sudirohusodo Hospital
Diana Tangdan Ampulembang, Irda Handayani, Nursin Abdul Kadir
INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY (2025) Vol. 31, Iss. 2, pp. 155-160
Open Access
The Protective Role of Folic Acid in Biochemical and Histopathological Changes Induced by Azithromycin in the Livers of Pregnant Albino Rats
Safaa M. Hanafy, Soha S. Zakaria
Medicina (2025) Vol. 61, Iss. 3, pp. 415-415
Open Access
Ethiopian antimicrobial consumption trends in human health sector: A surveillance report 2020–2022
Hailemariam Eshete, Melaku Tileku, Abiyot Aschenaki, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0319295-e0319295
Open Access
A Comprehensive Review on the Efficacy of Several Pharmacologic Agents for the Treatment of COVID-19
Fatma Haddad, Ghadeer Dokmak, Rafik Karaman
Life (2022) Vol. 12, Iss. 11, pp. 1758-1758
Open Access | Times Cited: 22
DP1, a multifaceted synthetic peptide: Mechanism of action, activity and clinical potential
Mayank Maan, Hemant Goyal, Shubhi Joshi, et al.
Life Sciences (2024) Vol. 340, pp. 122458-122458
Closed Access | Times Cited: 4
Increased antimicrobial resistance against azithromycin during COVID: role of irrational utilization
Sidra Tanwir, Arif Sabah, Ambrina Khatoon, et al.
Journal of the Pakistan Medical Association (2024) Vol. 74, Iss. 2, pp. 258-263
Open Access | Times Cited: 3
Exploring factors shaping antibiotic resistance patterns in Streptococcus pneumoniae during the 2020 COVID-19 pandemic
Aleksandra Kovacevic, David R. Smith, Eve Rahbé, et al.
eLife (2024) Vol. 13
Open Access | Times Cited: 3
Antibiotic utilization patterns in Tanzania: a retrospective longitudinal study comparing pre- and intra-COVID-19 pandemic era using Tanzania Medicines and Medical Devices Authority data
Raphael Zozimus Sangeda, Sahani M. William, Faustine Cassian Masatu, et al.
JAC-Antimicrobial Resistance (2024) Vol. 6, Iss. 3
Open Access | Times Cited: 2
VIRAL DISEASES AND THE ENVIRONMENT RELATIONSHIP
Caio Gonçalves do Amaral, Eduardo Pinto André, Eduardo Maffud Cilli, et al.
Environmental Pollution (2024), pp. 124845-124845
Closed Access | Times Cited: 2
Real-world evidence with a retrospective cohort of 15,968 COVID-19 hospitalized patients suggests 21 new effective treatments
Carlos Loucera, Rosario Carmona, Marina Esteban‐Medina, et al.
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 7
Azithromycin delivery via polymeric and non-polymeric nanoparticle systems: Expanding frontiers in cancer therapy
Mehrab Pourmadadi, Samin Tokasi, Sonia Fathi‐karkan, et al.
European Polymer Journal (2024) Vol. 216, pp. 113267-113267
Open Access | Times Cited: 1
Industrial Catalytic Production Process of Erythromycin
Theodora Adamantidi, Ellie Panoutsopoulou, Evangelia Stavrakoudi, et al.
Processes (2024) Vol. 12, Iss. 7, pp. 1533-1533
Open Access | Times Cited: 1
Epidemiology and Impact of Anti-Pneumococcal Vaccination and COVID-19 on Resistance of Streptococcus pneumoniae Causing Invasive Disease in Piedmont, Italy
Alessandro Bondi, Emanuele Koumantakis, Antonio Curtoni, et al.
Antibiotics (2024) Vol. 13, Iss. 8, pp. 740-740
Open Access | Times Cited: 1
A Nationwide Evaluation of Antibiotic Consumption in Kazakhstan from 2019 to 2023
Yuliya Semenova, Ademi Yergaliyeva, Ainur Aimurziyeva, et al.
Antibiotics (2024) Vol. 13, Iss. 12, pp. 1123-1123
Open Access | Times Cited: 1
Antibiotic Utilisation Patterns in Tanzania: A Retrospective Longitudinal Study Comparing Pre- and Post-COVID-19 Pandemic Using Tanzania Medicines and Medical Devices Authority Data
Raphael Zozimus Sangeda, Sahani M. William, Faustine Cassian Masatu, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Mapping the Lipid Signatures in COVID-19 Infection: Diagnostic and Therapeutic Solutions
Aishi Dasgupta, Shon Gangai, Rishikesh Narayan, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 21, pp. 14411-14433
Closed Access | Times Cited: 3
Interaction of Epigallocatechin Gallate and Quercetin with Spike Glycoprotein (S-Glycoprotein) of SARS-CoV-2: In Silico Study
Mehran Alavi, M. R. Mozafari, Saba Ghaemi, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3074-3074
Open Access | Times Cited: 5
Resistance patterns of bacterial pathogens causing lower respiratory tract infections: Aleppo-Syria
Ola Arab, Rawaa Al-Kayali, Abdullah Khouri, et al.
Annals of Medicine and Surgery (2023) Vol. 85, Iss. 6, pp. 2655-2661
Open Access | Times Cited: 2
Equity in the Cuban Policy Response Against the Pandemic
Jorge Luis Domínguez Martínez, Rodolfo Arozarena-Fundora, Ivette Arozarena Barbosa, et al.
(2024), pp. 291-310
Closed Access
Occurrence of COVID-19 in cystic fibrosis patients: a review
F Abolhasani, Masood Moein, Niloofar Rezaie, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access
The Impact of the COVID-19 Pandemic on Antimicrobial Usage: An International Patient-Level Cohort Study
Refath Farzana, Stephan Jürgen Harbarth, Ly‐Mee Yu, et al.
(2024)
Closed Access
A simple and rapid batch injection analysis method with amperometric detection for determination of azithromycin in pharmaceutical tablets
Lizandra N. Castro, Carlos E. C. Lopes, Domingos R. Santos-Neto, et al.
Ionics (2024)
Closed Access
Effects of a single oral dose of azithromycin in laboring women on antimicrobial resistance (AMR) and the microbiome: a protocol for the Antimicrobial Resistance Sub-Study of the A-PLUS trial
Jean Kim, Denise C. Babineau, Janet Moore, et al.
Gates Open Research (2024) Vol. 8, pp. 101-101
Open Access
Assessment of Azithromycin-Induced Toxicity in Caenorhabditis elegans: Effects on Morphology, Behavior, and Lipid Metabolism
Elisa Kalugendo, Aamir Nazir, Rakhi Agarwal
Toxicology Reports (2024) Vol. 13, pp. 101832-101832
Open Access
Page 1 - Next Page

Scroll to top